Review: taking Aleve and Buprenorphine hydrochloride together


Summary

Drug interactions are reported among people who take Aleve and Buprenorphine hydrochloride together. This review analyzes the effectiveness and drug interactions between Aleve and Buprenorphine hydrochloride. It is created by eHealthMe based on reports of 106 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Aleve and Buprenorphine hydrochloride >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Aleve

Aleve has active ingredients of naproxen sodium. It is often used in arthritis. (latest outcomes from Aleve 23,811 users)

Buprenorphine Hydrochloride

Buprenorphine hydrochloride has active ingredients of buprenorphine hydrochloride. It is often used in drug dependence. (latest outcomes from Buprenorphine hydrochloride 732 users)

On Aug, 24, 2016

106 people who take Aleve, Buprenorphine Hydrochloride are studied.


Number of reports submitted per year:

Aleve and Buprenorphine hydrochloride drug interactions.

Drug effectiveness over time:

Aleve:
  • < 1 month: 50.0% - (1 of 2 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Buprenorphine Hydrochloride:
  • < 1 month: 100.0% - (1 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 100.0% - (3 of 3 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Aleve:
  • female: 50.0% - (1 of 2 people)
  • male: 50.0% - (1 of 2 people)
Buprenorphine Hydrochloride:
  • female: 66.0% - (2 of 3 people)
  • male: 100.0% - (2 of 2 people)

Drug effectiveness by age:

Aleve:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 33.0% - (1 of 3 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 0.0% - (0 of 0 people)
Buprenorphine Hydrochloride:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 100.0% - (3 of 3 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 100.0% - (1 of 1 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • gastrointestinal haemorrhage
  • hallucinations, mixed
  • acute myocardial infarction
  • anaemia
  • asthenia
  • back pain
  • blood calcium decreased
  • blood glucose decreased
  • body tinea
  • disease progression
1 - 6 months:
  • delirium
  • depression
  • disorientation
  • hallucination
  • unresponsive to verbal stimuli
  • colitis ischaemic
  • depressed level of consciousness
  • hallucinations, mixed
  • large intestine perforation
  • peritonitis
6 - 12 months:
  • application site rash
  • furuncle
1 - 2 years:
  • chronic fatigue syndrome
  • diabetes mellitus
  • fibromyalgia
  • immunosuppressant drug level decreased
  • lupus
  • mastalgia
  • miscarriage
  • mobility decreased
  • myoclonic jerks
  • pain - joints
not specified:
  • pain
  • dyspnoea
  • pyrexia
  • nausea
  • arthralgia
  • palpitations
  • spinal osteoarthritis
  • diarrhoea
  • dry mouth
  • metastases to lung

Most common drug interactions by gender *:

female:
  • dyspnoea
  • pain
  • arthralgia
  • palpitations
  • spinal osteoarthritis
  • nausea
  • dry mouth
  • metastases to lung
  • osteoarthritis
  • pyrexia
male:
  • renal failure acute
  • lower respiratory tract infection
  • heart rate increased
  • pain
  • dehydration
  • blood calcium decreased
  • pyrexia
  • blood creatinine increased
  • depressed mood
  • lethargy

Most common drug interactions by age *:

20-29:
  • hypersensitivity
  • throat tightness
  • urticaria
  • abortion spontaneous
  • application site pain
  • drug exposure during pregnancy
  • dysphagia
  • dyspnoea
  • tonsillar hypertrophy
30-39:
  • hallucinations, mixed
  • abdominal rigidity
  • acidosis
  • chest discomfort
  • convulsion
  • delayed recovery from anaesthesia
  • dysphemia
  • dyspnoea
  • injury
  • pain
40-49:
  • depressed mood
  • lethargy
  • paranoia
  • chronic fatigue syndrome
  • colitis ischaemic
  • diabetes mellitus
  • fibromyalgia
  • immunosuppressant drug level decreased
  • large intestine perforation
  • lupus
50-59:
  • pyrexia
  • diarrhoea
  • dry mouth
  • neck pain
  • pulmonary oedema
  • respiratory failure
  • abdominal pain
  • arthralgia
  • dyspnoea
  • spinal osteoarthritis
60+:
  • pain
  • lower respiratory tract infection
  • renal failure acute
  • dehydration
  • heart rate increased
  • pyrexia
  • dyspnoea
  • arthralgia
  • blood calcium decreased
  • blood creatinine increased

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Aleve and Buprenorphine hydrochloride?

Can you answer these questions?

More questions for: Aleve, Buprenorphine hydrochloride

You may be interested in these reviews

More reviews for: Aleve, Buprenorphine hydrochloride

On eHealthMe, Aleve (naproxen sodium) is often used to treat arthritis. Buprenorphine hydrochloride (buprenorphine hydrochloride) is often used to treat drug dependence. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.